Healthtech Finland Launches Genomic Industry SIG

Thu, 10/05/2017 - 09:42

The board of Healthtech Finland has decided to launch Genomic Industry SIG  (Special Interest Group)  to work under the direction of Healthtech Finland in order to promote and share expertise in the genomic industry related issues. Abomics CEO, MD, PhD Jari Forsström has been chosen as the chairman of the established SIG. 

DiagFactor CEO Merja Auvinen has been chosen to act as the vice chairman and communications officer and Healthtech Finland CEO Saara Hassinen has been chosen as the secretary of the group. The newly established SIG will work on advancing the introduction of pharmacogenetics in clinical practice among other things.